Safety, Tolerability and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy in Patients Aged ≥ 65 Years with Focal Seizures

被引：0
|
作者：
Raquel Costa
Bernhard Steinhoff
Helena Gama
Fábio Ikedo
José-Francisco Rocha
Patrício Soares-da-Silva
机构：
[1] BIAL-Portela & Cª,Department of Research and Development
[2] S.A.,Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine
[3] Epilepsy Center Kork,MedInUP
[4] University of Porto,Center for Drug Discovery and Innovative Medicines
[5] University of Porto,undefined
来源：
Drugs & Aging | 2018年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1109 / 1117
页数：8
相关论文
共 50 条
  • [31] Safety and tolerability of eslicarbazepine acetate as monotherapy in patients with newly diagnosed partial-onset seizures
    Kowacs, P.
    Trinka, E.
    Ben-Menachem, E.
    Elger, C. E.
    Moreira, J.
    Pinto, R.
    Ikedo, F.
    Pereira, A.
    Rocha, J. F.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 770 - 770
  • [32] Safety and tolerability of eslicarbazepine acetate as monotherapy in patients with newly diagnosed partial-onset seizures
    Kowacs, Pedro Andre
    Trinka, Eugen
    Ben-Menachem, Elinor
    Elger, Christian
    Joana, Moreira
    Ikedo, Fabio
    Ana, Pereira
    Rocha, Jose Francisco
    Soares-da-Silva, Patricio
    NEUROLOGY, 2016, 87 (02) : E20 - E20
  • [33] Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures
    Chung, Steve
    Sinha, Saurabh R.
    Shah, Aashit
    Stern, John M.
    Cheng, Hailong
    Jung, JungAh
    Grinnell, Todd
    Blum, David
    EPILEPSY RESEARCH, 2019, 153 : 59 - 65
  • [34] EFFICACY AND TOLERABILITY OF LACOSAMIDE AS ADJUNCTIVE THERAPY IN PATIENTS WITH PHARMACORESISTANT FOCAL EPILEPSY
    Cappanera, S.
    Cesaroni, E.
    Zamponi, N.
    EPILEPSIA, 2011, 52 : 112 - 112
  • [35] Efficacy and Tolerability of Perampanel as Adjunctive Therapy in Chinese Patients With Focal-Onset Seizures: An Observational, Prospective Study
    Zhang, Ranran
    Qiao, Shan
    Fang, Xiqin
    Wang, Kemo
    Shi, Yanting
    Du, Qianwen
    Yang, Tingting
    Liu, Xuewu
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [36] Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam as their first adjunctive ASD
    Mehta, Darshan
    Davis, Matthew
    Epstein, Andrew J.
    Wensel, Brian
    Grinnell, Todd
    Thach, Andrew
    Williams, G. Rhys
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 939 - 948
  • [37] Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: Case series
    Gomez-Ibanez, A.
    Serratosa, J. M.
    Guillamon, E.
    Garces, M.
    Giraldez, B. G.
    Toledo, M.
    Salas-Puig, J.
    Lopez-Gonzalez, F. J.
    Rodriguez-Uranga, J.
    Castillo, A.
    Mauri, J. A.
    Camacho, J. L.
    Lopez-Gomariz, E.
    Giner, P.
    Torres, N.
    Palau, J.
    Molins, A.
    Villanueva, V.
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2017, 48 : 53 - 56
  • [38] SAFETY AND EFFICACY OF ESLICARBAZEPINE ACETATE IN ELDERLY PATIENTS
    Costa, R.
    Lopes, N.
    Gama, H.
    Sousa, R.
    Nunes, T.
    Soares-da-Silva, P.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (11):
  • [39] Effects of adjunctive eslicarbazepine acetate on neurocognitive functioning in children with refractory focal-onset seizures
    Jozwiak, Sergiusz
    Veggiotti, P.
    Moreira, J.
    Gama, H.
    Rocha, F.
    Soares-da-Silva, P.
    EPILEPSY & BEHAVIOR, 2018, 81 : 1 - 11
  • [40] Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy
    Ben-Menachem, E.
    Gabbai, A. A.
    Hufnagel, A.
    Maia, J.
    Almeida, L.
    Soares-da-Silva, P.
    EPILEPSY RESEARCH, 2010, 89 (2-3) : 278 - 285
12345